Fraud and Corruption Bring Big Payoffs

California judges provide stage for kangaroo court justice over Roundup weedkiller

By Paul Driessen – Re-Blogged From WUWT

San Francisco area juries have awarded cancer patients some $80 million each, based on claims that the active ingredient in Roundup weedkiller, caused their cancer – and that Bayer-Monsanto negligently or deliberately failed to warn consumers that the glyphosate it manufactures is carcinogenic. (It’s not.) Judges reduced the original truly outrageous awards of $289 million and even $1 billion per plaintiff!

Meanwhile, ubiquitous ads are still trolling for new clients, saying anyone who ever used Roundup and now has Non-Hodgkin Lymphoma or other cancer could be the next jackpot justice winner. Mass tort plaintiff law firms have lined up 18,500 additional “corporate victims” for glyphosate litigation alone.

Continue reading

Advertisements

A Personal Note.

By Bob Shapiro

Many of you know that I am living through Prostate Cancer. The treatments seem to be focused on using a couple of weeks here, or a couple of weeks there in an effort to add several months down the road.

I’ve had a good life- not that I’m rushing to say good-bye at 73 – and it’s been interesting to see how my priorities have been brought more clearly into focus.

I’ve been very happy sharing my ideas these last 5 years (whether I’ve written them or someone else) on my Blog and on Facebook. If you’ve found them worth your time enough to read some of them, well thank you.

Continue reading

Advance in Slowing Prostate Cancer Made in Clinical Trials

By Health Day – Re-Blogged From Newsmax Health

Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.

Two drugs that interfere with cancer’s ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that do not respond to regular therapy.

But these trials show the drugs also can improve survival and slow progression in prostate cancers that do respond to regular therapy, which typically involves medication that halts production of testosterone.

Study Proves Drug Cuts Prostate Cancer Risk

By Health Day – Re-Blogged From Newsmax Helth

Finasteride, best known as the enlarged-prostate medicine Proscar, is a safe, effective way to reduce the risk of prostate cancer, according to long-term findings from the Prostate Cancer Prevention Trial (PCPT).

The trial was funded by the U.S. National Cancer Institute and enrolled nearly 19,000 men between 1993 and 1997. Initially it found that finasteride — a hormone-blocking drug — cut the risk of prostate cancer by 25 percent. Those results were published in 2003.

The newly released long-term data show that the reduction of prostate cancer risk has continued and that fewer than 100 men in the trial died from prostate cancer in more than two decades of follow-up, according to a research team led by Dr. Ian Thompson.

Israeli Scientists Predict Cure for Cancer Within a Year

By Solange Reyner – Re-Blogged From Newsmax Health

Israeli scientists say they will likely have a cure for cancer within a year, according to The Jerusalem Post.

Dan Aridor, CEO of Accelerated Evolution Biotechnologies Ltd., said his team is developing an anti-cancer drug that will target several mutations in cancer cells using a combination of several-cancer directed peptides. The treatment is called MuTaTo, or multiobjective toxin.

“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor said. “Our solution will be both generic and personal.”

Continue reading

8 Health Hazards Caused by Lack of Vitamin D

By Lynn Allison – Re-Blogged From Newsmax Health

Our bodies need vitamin D for many health benefits but in the cold winter months it may be hard to get enough of this hormone that’s created when your skin is exposed to sunlight.

Without sufficient amounts of vitamin D, you could develop serious heart conditions and weakened bones. Children who have a vitamin D deficiency are at higher risk for developing rickets, a condition where their bones become soft and weak.

The Mayo Clinic recommends 400 international units or I.U.’s daily for children up to one year old, 600 I.U’s for those from one to 70 years of age and 800 I.U’s for folks over 70.

Serious Kidney Injury Common During Cancer Chemotherapy

By Thomson Reuters – Re-Blogged From Newsmax Health

Nearly one in 10 cancer patients treated with chemotherapy or newer targeted drugs may be hospitalized for serious kidney injury, a Canadian study suggests.

The study involved roughly 163,000 patients who started chemotherapy or targeted therapies for a new cancer diagnosis in Ontario from 2007 to 2014. Overall, 10,880 were hospitalized with serious kidney damage or for dialysis.

This translated into a cumulative acute kidney injury rate of 9.3 percent, the study found.

People with advanced tumors were 41 percent more likely to have acute kidney injuries than patients with early-stage cancer.